BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC is named as the registrant in 1 lobbying report we hold for 2026-Q2, for 1 client. 0 reports of 1 compared with the due date were posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client | Amount the report states, by quarter | Reports |
|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATIONThe registrant lobbying for itself | 2026-Q2: $710,000 in its own lobbying expenses | 1 |
Lobbyists named in these reports
- KATHARINE TROLLER BOND · 1 report
- RYAN DONNELLY · 1 report
- SARAH ELIZABETH NORDSTROM · 1 report
- WILLIAM DENT · 1 report
Bills named, and how the House and the Senate voted
8 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 842Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act | Reported by committee | No recorded vote in our record |
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1842PAW Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 7567Farm, Food, and National Security Act of 2026 | Passed the House | No recorded vote in our record |
| S. 339Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 1862ORPHAN Cures Act | Introduced | No recorded vote in our record |
Issues named: Animals (1), Budget/Appropriations (1), Health Issues (1), Medicare/Medicaid (1).
Every report
| Client | Kind, as filed | Posted | Report |
|---|---|---|---|
| BOEHRINGER INGELHEIM USA CORPORATIONBudget/Appropriations, Health Issues, Medicare/Medicaid, Animals | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
| Member | Paid to, as reported | Amount | Date | Report |
|---|---|---|---|---|
| Donald G. Davis DDemocrat | DON DAVIS FOR NCFrom BOEHRINGER INGELHEIM USA CORPORATION POLITICAL ACTION COMMITTEE BOEHRINGER PAC | $1,000 | The report on LDA.gov |
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.